Michael Weiser
CIK: 0001221449
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
IOVA
IOVANCE BIOTHERAPEUTICS, INC.
Director
Discretionary Trading P&L
Holdings
About WEISER MICHAEL
WEISER MICHAEL (SEC CIK 0001221449) files insider reports with the SEC as Director of IOVANCE BIOTHERAPEUTICS, INC. (IOVA).
Signal8 holds 2 ownership filings by WEISER MICHAEL, all Form 4s, filed between Jun 17, 2025 and Jun 18, 2026. Those filings report 2 transactions, from Jun 13, 2025 to Jun 16, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on WEISER MICHAEL's filings is in SAN CARLOS, CA.
Recent filings by WEISER MICHAEL
Other insiders filing for IOVANCE BIOTHERAPEUTICS, INC. (IOVA)
- Berkowitz Noah, Chief Medical Officer
- Vogt Frederick G, Interim CEO & General Counsel
- BILINSKY IGOR, Chief Operating Officer
- Puri Raj K., Chief Regulatory Officer
- Kirby Daniel Gordon, Chief Commercial Officer
- Roche Corleen M., Chief Financial Officer